Please note: This trial has finished recruiting and is not accepting new participants.

Research Center: CTI Clinical Research Center
Location: 1775 Lexington Ave, Suite 200, Cincinnati, OH
Lead Doctor: Dr Stephen J. Poland
Ethics Committee: This study has been reviewed and approved by the Schulman Institutional Review Board

Researcher interview:

Background

Over 30 million Americans suffer from migraines. Migraine is a debilitating disorder which includes throbbing headaches sometimes accompanied by nausea, vomiting and sensitivity to light and sound.

This research study is testing a new investigational drug for the treatment of migraine symptoms.

This study seeks men and women who currently suffer from migraines. Participants are required to attend 3 study visits at the research site over 3 months and may be compensated up to $455 for participating in this study.

Benefits of Participation

• You may be compensated up to $455 for participating in this study.
• You may be helping to advance medical research.

Your Rights

• If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
• Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
• Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

• Men and women aged 18+ who suffer from migraines for more than 1 year
• Experience about 2 – 8 migraines per month
• Otherwise healthy
• Able to attend 3 study visits at the research site over approximately 3 months